Sun State Partners

Big news for millions dealing with sleep apnea! 🌙💤

The FDA has just approved the **first-ever medication** specifically for treating moderate to severe **obstructive sleep apnea (OSA)** in adults with obesity. It's called **Zepbound (tirzepatide)** — the same drug already known for weight loss — and it's to be used along with a reduced-calorie diet and more physical activity.

In clinical trials, Zepbound significantly reduced breathing interruptions during sleep (measured by the apnea-hypopnea index) and helped many patients achieve remission or much milder symptoms after 52 weeks. It works by activating gut hormones to curb appetite, promote weight loss, and improve OSA as a result.

This is a major step forward — as the FDA noted: “Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea.” (Previously, options like CPAP machines were the main go-to.)

If you or someone you know struggles with OSA and obesity, talk to a doctor about whether this could be an option. Always check for side effects and suitability — it's not for everyone.

What do you think — game-changer for sleep health? 😴

Source: FDA announcement (Dec 2024).

FDA Approves First Medication for Obstructive Sleep Apnea Today, the FDA approved the first medication for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Recently unveiled updated Medicare Supplement rates tailored to your zip code!

✔️ No referrals required with a Medicare Supplement Policy.

✔️ Eliminate out-of-pocket expenses with a Medicare Supplement Policy.

fb.me